They have now revised there SELL recommendation to a Spec BUY. Now we have NO negative views on BTR of what I can see..
Again all good for the upcoming ASX300 listing.
- Forums
- ASX - By Stock
- BTR
- cbgf research
cbgf research, page-19
Featured News
Add BTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
-0.003(11.1%) |
Mkt cap ! $171.1M |
Open | High | Low | Value | Volume |
2.5¢ | 2.5¢ | 2.4¢ | $234.6K | 9.448M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 3523161 | 2.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.5¢ | 6019055 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 3523161 | 0.024 |
24 | 10139252 | 0.023 |
40 | 9900453 | 0.022 |
20 | 3290755 | 0.021 |
34 | 7517084 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.025 | 6019055 | 7 |
0.026 | 3687650 | 9 |
0.027 | 6866294 | 11 |
0.028 | 4258845 | 10 |
0.029 | 4137037 | 4 |
Last trade - 12.46pm 12/11/2024 (20 minute delay) ? |
Featured News
BTR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online